Genetic diversity of Plasmodium falciparum and its implications in the epidemiology of malaria

Programa de Estudio y Control de Enfermedades Tropicales, Medellín, Colombia.
Biomédica: revista del Instituto Nacional de Salud (Impact Factor: 0.55). 01/2006; 25(4):588-602.
Source: PubMed


Genetic diversity provides Plasmodium falciparum with the potential capacity of avoiding the immune response, and possibly supporting the selection of drug or vaccine resistant parasites. These genetic characters play key roles in the selection of appropriate malaria control measures. Diverse clones of Plasmodium falciparum, often denoted as strains, has been documented, and the degree of genetic diversity supported by several kinds of PCR (polymerase chain reaction) assays. Many studies in different endemic regions with differences in their level of disease transmission have clarified the interactions between the parasite populations and malaria epidemiology. This paper describes recombination events of the malaria parasite life cycle that originate such genetic diversity in P. falciparum, reviewing different studies on this aspect and its implications in the immunity and development of control measures in regions with different degrees of endemicity.

Download full-text


Available from: Judy Natalia Jiménez, Jul 22, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The development of Plasmodium falciparum resistant to antimalarial drugs constitutes a major public health issue for malaria control. Particularly, the emergence and widespread of chloroquine resistant P. falciparum strains in the second half of XX century represents a new challenge to malaria control. The scientific literature has documented factors related to the human host, the vector, the parasite and the treatment, which could explain the selection, survival and local or wide spread of these strains. In this paper are reviewed non-biological factors that could explain the emergency of P. falciparum resistant chloroquine strains. The understanding of these factors is relevant to design strategies to delay the emergence of antimalarial drug resistant parasites.
    Full-text · Article · Jun 2011
  • [Show abstract] [Hide abstract]
    ABSTRACT: Malaria is one of the world׳s most widespread parasitic diseases. The parasitic protozoans of the genus Plasmodium have developed resistance to several antimalarial drugs. Some patients are therefore infected by two or more strains with different levels of antimalarial drug sensitivity. We previously developed a model to estimate the drug concentration (IC50)(IC50) that inhibits 50% of the growth of the parasite isolated from a patient infected with one strain. We propose here a new Two-Slopes model for patients infected by two strains. This model involves four parameters: the proportion of each strain and their IC50, and the sigmoidicity parameter. To estimate the parameters of this model, we developed a new algorithm called PGBO (Population Genetics-Based Optimizer). It is based on the Metropolis–Hasting algorithm and is implemented in the statistical software R. We performed a simulation study and defined three evaluation criteria to evaluate its properties and compare it with three other algorithms (Gauss–Newton, Levenberg–Marquardt, and a simulated annealing). We also evaluated it using in vitro data and three ex vivo datasets from the French Malaria Reference Center. Our evaluation criteria in the simulation show that PGBO gives good estimates of the parameters even if the concentration design is poor. Moreover, our algorithm is less sensitive than Gauss–Newton algorithms to initial values. Although parameter estimation is good, interpretation of the results can be difficult if the proportion of the second strain is close to 0 or 1. For these reasons, this approach cannot yet be implemented routinely.
    No preview · Article · Dec 2014 · Computers in Biology and Medicine